5-Aminosalicylic Acid Therapy and the Risk of Colorectal Cancer Among Patients with Inflammatory Bowel Disease

Abstract

Treating IBD patients with 5-ASA medications was not found to have a protective effect against colitis-related CRC when assessed over a short period of exposure.